Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2025 - 14:55

Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Date of authorisation: 13/07/2011, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2025 - 13:48

Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Date of authorisation: 13/07/2011, Revision: 21, Status: Authorised

Annex IV questions and answers – Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices

Submitted by Anonymous (not verified) on 10 July 2025 - 13:00

Annex IV questions and answers – Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices

Annex II questions and answers – Fees, charges and remuneration for assessment procedures and services relating to veterinary medicinal products

Submitted by Anonymous (not verified) on 10 July 2025 - 13:00

Annex II questions and answers – Fees, charges and remuneration for assessment procedures and services relating to veterinary medicinal products

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More